Skip to content

Higher fiber intake was associated with cancer immunotherapy response

Human observational studies linked higher fiber consumption with better treatment response. Mouse experiments also examined dietary changes, but cannot establish that those changes improve outcomes in patients.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Among cancer patients receiving immune checkpoint inhibitors, a type of immunotherapy, higher fiber consumption was associated with better treatment response than lower consumption. The human evidence was observational, so it cannot establish that fiber caused the difference. Findings about fasting or restricted nutrients in mice do not demonstrate dietary benefits for patients.

Keep in mind

The abstract provides no confidence interval, follow-up period or definition of higher versus lower fiber intake for the pooled human estimate. Observational findings cannot establish a dietary treatment effect.

THE NUMBERS, WITH CONTEXT

What researchers found

5.79 times the response odds in lower-fiber groups

Therapeutic response in human prospective cohorts

Higher versus lower fiber consumption: pooled odds ratio 5.79. Follow-up length and confidence interval were not reported.

J Transl Med, 2025 · Original source ↓

What response odds mean

Odds compare the chance of responding with the chance of not responding within a group. The pooled ratio compares those odds between dietary groups; it does not mean response probability was multiplied by the same amount.

Mouse outcomes are different

Mouse experiments measured tumor size after dietary changes, including fasting and restricted nutrient availability. Human studies examined response and survival outcomes. These different endpoints and populations limit how directly the animal findings can inform conclusions about patients.

CHECK THE ORIGINAL

The original publication

Gut microbiome changes and cancer immunotherapy outcomes associated with dietary interventions: a systematic review of preclinical and clinical evidence.

Somodi C, Dora D, Horváth M et al.
J Transl Med · 2025

PubMed ID
40629403
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.